IS3987A - Preparations containing N- (phosphonoacetyl) -L-aspartic acid and methods for their use as a broad antiviral agent - Google Patents

Preparations containing N- (phosphonoacetyl) -L-aspartic acid and methods for their use as a broad antiviral agent

Info

Publication number
IS3987A
IS3987A IS3987A IS3987A IS3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A
Authority
IS
Iceland
Prior art keywords
phosphonoacetyl
methods
aspartic acid
antiviral agent
preparations containing
Prior art date
Application number
IS3987A
Other languages
Icelandic (is)
Inventor
A. Blough Herbert
Original Assignee
U.S. Bioscience, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,234 external-priority patent/US5491135A/en
Application filed by U.S. Bioscience, Inc. filed Critical U.S. Bioscience, Inc.
Publication of IS3987A publication Critical patent/IS3987A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS3987A 1992-03-18 1993-03-18 Preparations containing N- (phosphonoacetyl) -L-aspartic acid and methods for their use as a broad antiviral agent IS3987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85345492A 1992-03-18 1992-03-18
US08/032,234 US5491135A (en) 1992-03-18 1993-03-17 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals

Publications (1)

Publication Number Publication Date
IS3987A true IS3987A (en) 1993-09-19

Family

ID=26708159

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3987A IS3987A (en) 1992-03-18 1993-03-18 Preparations containing N- (phosphonoacetyl) -L-aspartic acid and methods for their use as a broad antiviral agent

Country Status (10)

Country Link
EP (1) EP0660710A1 (en)
JP (1) JPH07507770A (en)
CN (1) CN1080853A (en)
AU (1) AU3965993A (en)
BR (1) BR9306123A (en)
CA (1) CA2109435C (en)
IL (1) IL105090A (en)
IS (1) IS3987A (en)
MX (1) MX9301527A (en)
WO (1) WO1993018763A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
CA2309321A1 (en) 1997-11-10 1999-05-20 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
AU762125B2 (en) 1998-02-12 2003-06-19 G.D. Searle & Co. Use of (N)-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
AU3595500A (en) 1999-02-12 2000-08-29 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
EP1239923A2 (en) * 1999-12-20 2002-09-18 New Pharma Research Sweden AB Stabilized veterinary compositions comprising more than one antiviral agent
DE10138912A1 (en) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
DE10343365A1 (en) * 2003-09-17 2005-04-14 Biosphings Ag Pharmaceutical Formulations of Xanthogenates and Inhibitors of Viral Nucleic Acid Replication
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
CN111317733B (en) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 Application of rifamycin antibiotics in preparation of drugs for resisting yellow fever virus infection
WO2021189444A1 (en) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 Use of rifamycin antibiotics in preparation of drugs against yellow fever virus infections
CN111419839A (en) * 2020-03-31 2020-07-17 远见生物科技（上海）有限公司 New application of rifamycin
EP4162952A4 (en) * 2020-04-30 2024-08-21 Univ Kyoto Prophylactic or therapeutic agent for rna virus-related diseases
WO2022200615A1 (en) * 2021-03-26 2022-09-29 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Pyrimidine biosynthesis inhibitor combination for use in treating viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid

Also Published As

Publication number Publication date
JPH07507770A (en) 1995-08-31
EP0660710A1 (en) 1995-07-05
IL105090A (en) 1998-08-16
MX9301527A (en) 1994-02-28
AU3965993A (en) 1993-10-21
CA2109435C (en) 1997-03-11
EP0660710A4 (en) 1995-03-02
WO1993018763A1 (en) 1993-09-30
IL105090A0 (en) 1994-08-26
CA2109435A1 (en) 1993-09-19
BR9306123A (en) 1997-08-26
CN1080853A (en) 1994-01-19

Similar Documents

Publication Publication Date Title
IS3987A (en) Preparations containing N- (phosphonoacetyl) -L-aspartic acid and methods for their use as a broad antiviral agent
GB1548553A (en) Addition compound of dipeptide derivative and amino acid derivative
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
ZA892922B (en) Biphenylacetic acid gel(3%)
HU906721D0 (en) Methylene-diphosphonic acid derivatives and inflammation-preventing preparations containing them as active agents
ZA931934B (en) Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
NO930760L (en) SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
DE3279468D1 (en) Peptide synthesis and amino acid blocking agents
GB8524879D0 (en) N-substituted amino acid derivatives
JPS57118564A (en) Amino acid derivative and manufacture
PH15717A (en) N-(1-(3-benzoylpropyl)-4-piperidyl)-sulfonic acid amides and salts thereof
NO930722L (en) IMIDAZOLYL-SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
DE59107135D1 (en) Phosphonic acid and thionophosphonic acid derivatives
IL72157A (en) 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them
DK156484A (en) AMINO ACID DERIVATIVES
DK438283D0 (en) ACID STABLE ALPHA AMYLASEENZYM PRODUCT AND PREPARATION thereof
ZA893199B (en) Amino acid derivatives
ZA892720B (en) Amino acid derivatives
DK489384A (en) 6ALFA- (1-HYDROXYETHYL) -2- (DIOXACYCLOALKYL) ALKYLTHIO-2-PENEM-3-CARBOXYLIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS
DK489584A (en) 6ALFA- (1-HYDROXYETHYL) -2-AZACYCLOALKYLTHIO-2-PENEM-3-CARBOXYLIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS
IL72602A (en) 2(5-isopropyl-5-methyl-4-oxo-1-imidazolin-2-yl)benzoic acid analogs and use thereof as herbicidal agents
ZA899114B (en) Amino acid derivatives
JPS5481205A (en) Amine and amino acid derivatives
DK344384D0 (en) 2-HETEROCYCLYLALKYLTHIO-6- (ALFA-HYDROXYETHYL) -2-PENEM-3-CARBOXYLIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
ZA892059B (en) Amino acid derivatives